Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.30 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL703497 | 0.97 | LMNA (0.35) | LMNATSHRTHRBEPHX1 | |
| SCHEMBL703661 | 0.97 | LMNA (0.35) | LMNATSHRTHRBEPHX1 | |
| SCHEMBL707567 | 0.97 | LMNA (0.35) | LMNATSHRTHRBEPHX1 | |
| SCHEMBL3481732 | 0.94 | LMNA (0.34) | LMNATSHRTHRB | |
| SCHEMBL16497600 | 0.94 | LMNA (0.39) | LMNATSHRTHRBEPHX1 | |
| SCHEMBL3481472 | 0.94 | LMNA (0.34) | LMNATSHRTHRB | |
| SCHEMBL613246 | 0.91 | LMNA (0.40) | LMNATSHRTHRBEPHX1 | |
| SCHEMBL19356773 | 0.88 | TSHR (0.44) | LMNATSHRTHRBEPHX1 | |
| SCHEMBL3482907 | 0.88 | LMNA (0.34) | LMNATSHRTHRB | |
| SCHEMBL612829 | 0.88 | TSHR (0.44) | LMNATSHRTHRBEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 569 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119627216-A | Electrolyte for inhibiting circulating gas production of sodium ion battery and preparation method and application thereof | 湖南法恩莱特新能源科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| WO-2024232632-A1 | TRANSITION METAL SUPPORTED CATALYST WITH IMPROVED HYDROGENATION ACTIVITY AND USE THEREOF | 한양대학교 산학협력단 | 2024-11-14 | — | — | WO | claimed |
| CN-118909171-A | Solid catalyst component for olefin polymerization reaction, preparation method and application thereof | 中国石油化工股份有限公司 | 2024-11-08 | — | — | CN | claimed |
| CN-115155113-B | Structure for organic silicon defoamer and synthesis method thereof | 佛山市南海大田化学有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-115105868-B | Organic silicon defoamer and preparation method thereof | 佛山市南海大田化学有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-115105868-A | Organic silicon defoaming agent and preparation method thereof | 佛山市南海大田化学有限公司 | 2022-09-27 | — | — | CN | claimed |
| CN-114106458-A | Irradiation modified PP melt-blown material and composite forming process thereof | 中核同辐（长春）辐射技术有限公司 | 2022-03-01 | — | — | CN | claimed |
| US-11059920-B2 | Process for producing high cis-1,4-polydiene with lanthanide-based catalyst compositions | BRIDGESTONE CORPORATION (JP) | 2021-07-13 | — | — | US | claimed |
| WO-2021118145-A1 | METHOD FOR PREPARING OLEFIN-BASED POLYMER BY GAS-PHASE POLYMERIZATION | 한화솔루션 주식회사 | 2021-06-17 | — | — | WO | claimed |
| US-20190169330-A1 | Process For Producing High Cis-1,4-Polydiene With Lanthanide-Based Catalyst Compositions | BRIDGESTONE CORPORATION (JP) | 2019-06-06 | — | — | US | claimed |
| US-20060189163-A1 | Method of forming thick silica-based film | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 2006-08-24 | — | — | US | claimed |
| US-20050288525-A1 | Reagents for asymmetric allylation, aldol, and tandem aldol and allylation reactions | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-12-29 | — | — | US | claimed |
| WO-2005090282-A1 | ANDROGEN RECEPTOR MODULATOR COMPOUNDS AND METHODS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2005-09-29 | — | — | WO | claimed |
| CN-1220627-C | Method for manufacturing hydrophobic colloidal silica | DSM IP N V (NL) | 2005-09-28 | — | — | CN | claimed |
| EP-1480988-A1 | REAGENTS FOR ASYMMETRIC ALLYLATION, ALDOL, AND TANDEM ALDOL AND ALLYLATION REACTIONS | The Trustees of Columbia University in the City of New York (US) | 2004-12-01 | — | — | EP | claimed |
| EP-1252095-B1 | METHOD FOR MANUFACTURING HYDROPHOBIC COLLOIDAL SILICA | DSM IP ASSETS BV (NL) | 2004-11-10 | — | — | EP | claimed |
| WO-2003074534-A9 | REAGENTS FOR ASYMMETRIC ALLYLATION, ALDOL, AND TANDEM ALDOL AND ALLYLATION REACTIONS | UNIV COLUMBIA (US) | 2003-11-20 | — | — | WO | claimed |
| WO-2003074534-A1 | REAGENTS FOR ASYMMETRIC ALLYLATION, ALDOL, AND TANDEM ALDOL AND ALLYLATION REACTIONS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2003-09-12 | — | — | WO | claimed |
| CN-1429178-A | Method for manufacturing hydrophobic colloidal silica | DSM NV (NL) | 2003-07-09 | — | — | CN | claimed |
| US-20030035888-A1 | Method for manufacturing hydrophobic colloidal silica | JSR CORPORATION (JP) | 2003-02-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288525-A1 | Reagents for asymmetric allylation, aldol, and tandem aldol and allylation reactions | AKR1C3, AKR1B10, CBR3 | LMNA 1028/4885TSHR 349/4885THRB 1735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.